lystn

Podcast Series Title: The 411 on a GLP-1

Podcast Series Description: Join series host Dr. Jim Gavin, Clinical Professor of Medicine at Emory University and Chief Medical Officer for Healing our Village in Atlanta, Georgia, and fellow leaders in the field of diabetes as they tackle some of the challenges we face when treating T2D. Topics of discussion include clinical inertia, as well as the mechanism of action, dosing, efficacy, and safety of a GLP-1 RA for adults with T2D. 

This podcast is sponsored by Novo Nordisk and is intended for clinicians.

 Episode Title: Could This GLP-1 RA be Right for Your Adult Patients With T2D?

Episode Description: Join leaders in the field of diabetes Dr. Jim Gavin, Dr. Pablo Mora, and Dr. Bob Busch as they navigate through a clinical study. What do you need to know about using a GLP-1 RA for glycemic control with patients who have T2D? Are there any considerations for specific populations such as those who have moderate renal impairment? 

This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only.

Faculty Presenters:

 James R. Gavin III, MD, PhD
Clinical Professor of Medicine, Emory University
Chief Medical Officer, Healing Our Village, Inc.
Atlanta, Georgia

 Robert Busch, MD
Director of Clinical Research
Albany Med Faculty Practice, Community Endocrine Group
Albany, New York 

 Pablo F. Mora, MD, FACE, MSc, CDCES
Endocrinologist, North Texas Diabetes & Endocrinology
Clinical Professor, Division of Endocrinology at University of Texas 
Southwestern Medical Center
Dallas, Texas